SK8222003A3 - Use of a biological material containing three-dimensional scaffolds of hyaluronic acid derivatives for the preparation of implants in arthroscopy and kit for instruments for implanting said biological material by arthroscopy - Google Patents

Use of a biological material containing three-dimensional scaffolds of hyaluronic acid derivatives for the preparation of implants in arthroscopy and kit for instruments for implanting said biological material by arthroscopy Download PDF

Info

Publication number: SK8222003A3
Authority: SK; Slovakia
Prior art keywords: hyaluronic acid; biological material; acid; group; use according
Prior art date: 2000-12-28

Application number

SK822-2003A

Other languages

English (en)

Slovak (sk)

Inventor

Lanfranco Callegaro

Maurilio Marcacci

Fede Sergio Di

Original Assignee

Fidia Advanced Biopolymers Srl

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-28

Filing date

2001-12-27

Publication date

2003-10-07

2000-12-28 Priority claimed from ITMI20002845 external-priority patent/IT1320141B1/it

2001-04-12 Priority claimed from IT2001PD000090A external-priority patent/ITPD20010090A1/it

2001-12-27 Application filed by Fidia Advanced Biopolymers Srl filed Critical Fidia Advanced Biopolymers Srl

2003-10-07 Publication of SK8222003A3 publication Critical patent/SK8222003A3/sk

Links

KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical class CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title claims abstract description 48
239000012620 biological material Substances 0.000 title claims abstract description 38
238000002360 preparation method Methods 0.000 title claims abstract description 7
239000007943 implant Substances 0.000 title description 2
210000004027 cell Anatomy 0.000 claims description 28
229920002674 hyaluronan Polymers 0.000 claims description 22
229960003160 hyaluronic acid Drugs 0.000 claims description 22
238000000034 method Methods 0.000 claims description 22
210000000845 cartilage Anatomy 0.000 claims description 21
230000003902 lesion Effects 0.000 claims description 21
210000001612 chondrocyte Anatomy 0.000 claims description 18
102000008186 Collagen Human genes 0.000 claims description 13
108010035532 Collagen Proteins 0.000 claims description 13
229920001436 collagen Polymers 0.000 claims description 13
230000003833 cell viability Effects 0.000 claims description 12
KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 12
229920000615 alginic acid Polymers 0.000 claims description 11
235000010443 alginic acid Nutrition 0.000 claims description 11
229920000936 Agarose Polymers 0.000 claims description 10
238000002513 implantation Methods 0.000 claims description 9
GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 claims description 8
229920001817 Agar Polymers 0.000 claims description 8
229920002101 Chitin Polymers 0.000 claims description 8
229920001661 Chitosan Polymers 0.000 claims description 8
229920002683 Glycosaminoglycan Polymers 0.000 claims description 8
239000008272 agar Substances 0.000 claims description 8
230000000735 allogeneic effect Effects 0.000 claims description 8
239000001913 cellulose Substances 0.000 claims description 8
229920002678 cellulose Polymers 0.000 claims description 8
229920001206 natural gum Polymers 0.000 claims description 8
239000001814 pectin Substances 0.000 claims description 8
235000010987 pectin Nutrition 0.000 claims description 8
229920003175 pectinic acid Polymers 0.000 claims description 8
229920001059 synthetic polymer Polymers 0.000 claims description 8
229920001285 xanthan gum Polymers 0.000 claims description 8
229920002230 Pectic acid Polymers 0.000 claims description 7
239000000783 alginic acid Substances 0.000 claims description 7
229960001126 alginic acid Drugs 0.000 claims description 7
150000004781 alginic acids Chemical class 0.000 claims description 7
LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 claims description 7
239000010318 polygalacturonic acid Substances 0.000 claims description 7
150000003839 salts Chemical class 0.000 claims description 7
238000001356 surgical procedure Methods 0.000 claims description 7
229920002148 Gellan gum Polymers 0.000 claims description 6
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 6
150000002148 esters Chemical class 0.000 claims description 6
125000000524 functional group Chemical group 0.000 claims description 6
239000003102 growth factor Substances 0.000 claims description 6
239000012528 membrane Substances 0.000 claims description 6
150000004804 polysaccharides Chemical class 0.000 claims description 6
239000004814 polyurethane Substances 0.000 claims description 6
229920002635 polyurethane Polymers 0.000 claims description 6
239000001384 succinic acid Substances 0.000 claims description 6
229920000954 Polyglycolide Polymers 0.000 claims description 5
-1 antimicotics Substances 0.000 claims description 5
229920001577 copolymer Polymers 0.000 claims description 5
239000004633 polyglycolic acid Substances 0.000 claims description 5
229920002472 Starch Polymers 0.000 claims description 4
239000004480 active ingredient Substances 0.000 claims description 4
150000001299 aldehydes Chemical class 0.000 claims description 4
125000001931 aliphatic group Chemical group 0.000 claims description 4
125000003118 aryl group Chemical group 0.000 claims description 4
239000003795 chemical substances by application Substances 0.000 claims description 4
150000004985 diamines Chemical class 0.000 claims description 4
150000001991 dicarboxylic acids Chemical class 0.000 claims description 4
238000005553 drilling Methods 0.000 claims description 4
239000000499 gel Substances 0.000 claims description 4
150000004820 halides Chemical class 0.000 claims description 4
125000000623 heterocyclic group Chemical group 0.000 claims description 4
229920005615 natural polymer Polymers 0.000 claims description 4
229920000747 poly(lactic acid) Polymers 0.000 claims description 4
229920002627 poly(phosphazenes) Polymers 0.000 claims description 4
239000004626 polylactic acid Substances 0.000 claims description 4
229920000642 polymer Polymers 0.000 claims description 4
229920001282 polysaccharide Polymers 0.000 claims description 4
239000005017 polysaccharide Substances 0.000 claims description 4
239000004810 polytetrafluoroethylene Substances 0.000 claims description 4
229920001343 polytetrafluoroethylene Polymers 0.000 claims description 4
239000002244 precipitate Substances 0.000 claims description 4
239000002243 precursor Substances 0.000 claims description 4
239000011347 resin Substances 0.000 claims description 4
229920005989 resin Polymers 0.000 claims description 4
239000008107 starch Substances 0.000 claims description 4
235000019698 starch Nutrition 0.000 claims description 4
239000003242 anti bacterial agent Substances 0.000 claims description 3
239000002260 anti-inflammatory agent Substances 0.000 claims description 3
229940121363 anti-inflammatory agent Drugs 0.000 claims description 3
230000000416 anti-micotic effect Effects 0.000 claims description 3
229940088710 antibiotic agent Drugs 0.000 claims description 3
239000003443 antiviral agent Substances 0.000 claims description 3
239000004745 nonwoven fabric Substances 0.000 claims description 3
210000004409 osteocyte Anatomy 0.000 claims description 3
210000000130 stem cell Anatomy 0.000 claims description 3
125000003158 alcohol group Chemical group 0.000 claims description 2
150000001298 alcohols Chemical class 0.000 claims description 2
238000004132 cross linking Methods 0.000 claims description 2
150000004676 glycans Polymers 0.000 claims description 2
229910001385 heavy metal Inorganic materials 0.000 claims description 2
229910052751 metal Inorganic materials 0.000 claims description 2
239000002184 metal Substances 0.000 claims description 2
150000003242 quaternary ammonium salts Chemical class 0.000 claims description 2
125000006850 spacer group Chemical group 0.000 claims description 2
230000001954 sterilising effect Effects 0.000 claims description 2
150000005846 sugar alcohols Polymers 0.000 claims description 2
DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical compound CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 claims description 2
ZNEOHLHCKGUAEB-UHFFFAOYSA-N trimethylphenylammonium Chemical compound C[N+](C)(C)C1=CC=CC=C1 ZNEOHLHCKGUAEB-UHFFFAOYSA-N 0.000 claims description 2
230000008014 freezing Effects 0.000 claims 2
238000007710 freezing Methods 0.000 claims 2
238000003780 insertion Methods 0.000 claims 2
230000037431 insertion Effects 0.000 claims 2
239000000463 material Substances 0.000 description 12
210000001519 tissue Anatomy 0.000 description 12
230000007547 defect Effects 0.000 description 8
210000001188 articular cartilage Anatomy 0.000 description 6
238000011084 recovery Methods 0.000 description 5
238000000338 in vitro Methods 0.000 description 4
238000004806 packaging method and process Methods 0.000 description 4
108010073385 Fibrin Proteins 0.000 description 3
102000009123 Fibrin Human genes 0.000 description 3
BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 3
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
229910000831 Steel Inorganic materials 0.000 description 3
230000008901 benefit Effects 0.000 description 3
230000001413 cellular effect Effects 0.000 description 3
229950003499 fibrin Drugs 0.000 description 3
239000011159 matrix material Substances 0.000 description 3
230000004048 modification Effects 0.000 description 3
238000012986 modification Methods 0.000 description 3
230000008569 process Effects 0.000 description 3
239000010959 steel Substances 0.000 description 3
238000012795 verification Methods 0.000 description 3
230000035899 viability Effects 0.000 description 3
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
206010061762 Chondropathy Diseases 0.000 description 2
238000000134 MTT assay Methods 0.000 description 2
231100000002 MTT assay Toxicity 0.000 description 2
238000004113 cell culture Methods 0.000 description 2
230000024245 cell differentiation Effects 0.000 description 2
238000003776 cleavage reaction Methods 0.000 description 2
238000005520 cutting process Methods 0.000 description 2
230000006378 damage Effects 0.000 description 2
230000007850 degeneration Effects 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
239000004744 fabric Substances 0.000 description 2
210000002950 fibroblast Anatomy 0.000 description 2
210000000968 fibrocartilage Anatomy 0.000 description 2
210000004276 hyalin Anatomy 0.000 description 2
210000003035 hyaline cartilage Anatomy 0.000 description 2
238000010348 incorporation Methods 0.000 description 2
238000011534 incubation Methods 0.000 description 2
210000003127 knee Anatomy 0.000 description 2
239000002609 medium Substances 0.000 description 2
230000006609 metabolic stress Effects 0.000 description 2
230000003287 optical effect Effects 0.000 description 2
239000000047 product Substances 0.000 description 2
230000007017 scission Effects 0.000 description 2
230000004936 stimulating effect Effects 0.000 description 2
230000000638 stimulation Effects 0.000 description 2
239000000126 substance Substances 0.000 description 2
238000012360 testing method Methods 0.000 description 2
238000002054 transplantation Methods 0.000 description 2
FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
206010007710 Cartilage injury Diseases 0.000 description 1
102000029816 Collagenase Human genes 0.000 description 1
108060005980 Collagenase Proteins 0.000 description 1
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 1
241000282412 Homo Species 0.000 description 1
101001052035 Homo sapiens Fibroblast growth factor 2 Proteins 0.000 description 1
101000976075 Homo sapiens Insulin Proteins 0.000 description 1
101000851176 Homo sapiens Pro-epidermal growth factor Proteins 0.000 description 1
102000055008 Matrilin Proteins Human genes 0.000 description 1
108010072582 Matrilin Proteins Proteins 0.000 description 1
229920002732 Polyanhydride Polymers 0.000 description 1
102000046299 Transforming Growth Factor beta1 Human genes 0.000 description 1
101800002279 Transforming growth factor beta-1 Proteins 0.000 description 1
241000700605 Viruses Species 0.000 description 1
238000005299 abrasion Methods 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
230000009471 action Effects 0.000 description 1
239000013543 active substance Substances 0.000 description 1
230000002776 aggregation Effects 0.000 description 1
238000004220 aggregation Methods 0.000 description 1
229940072056 alginate Drugs 0.000 description 1
230000033115 angiogenesis Effects 0.000 description 1
230000000845 anti-microbial effect Effects 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
229960005070 ascorbic acid Drugs 0.000 description 1
235000010323 ascorbic acid Nutrition 0.000 description 1
239000011668 ascorbic acid Substances 0.000 description 1
239000003364 biologic glue Substances 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
230000031018 biological processes and functions Effects 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
238000001574 biopsy Methods 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
230000037396 body weight Effects 0.000 description 1
210000001185 bone marrow Anatomy 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
230000004663 cell proliferation Effects 0.000 description 1
238000013043 cell viability test Methods 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
230000008859 change Effects 0.000 description 1
230000002648 chondrogenic effect Effects 0.000 description 1
239000000512 collagen gel Substances 0.000 description 1
229960002424 collagenase Drugs 0.000 description 1
238000007398 colorimetric assay Methods 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
230000003412 degenerative effect Effects 0.000 description 1
230000006866 deterioration Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
229960001760 dimethyl sulfoxide Drugs 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
210000003414 extremity Anatomy 0.000 description 1
239000012894 fetal calf serum Substances 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
239000008187 granular material Substances 0.000 description 1
230000012010 growth Effects 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
230000036571 hydration Effects 0.000 description 1
238000006703 hydration reaction Methods 0.000 description 1
230000028993 immune response Effects 0.000 description 1
239000007972 injectable composition Substances 0.000 description 1
PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 description 1
210000002510 keratinocyte Anatomy 0.000 description 1
238000013150 knee replacement Methods 0.000 description 1
230000033001 locomotion Effects 0.000 description 1
230000007774 longterm Effects 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
238000013507 mapping Methods 0.000 description 1
239000004005 microsphere Substances 0.000 description 1
230000001338 necrotic effect Effects 0.000 description 1
GVUGOAYIVIDWIO-UFWWTJHBSA-N nepidermin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C1=CC=C(O)C=C1 GVUGOAYIVIDWIO-UFWWTJHBSA-N 0.000 description 1
230000008520 organization Effects 0.000 description 1
230000000399 orthopedic effect Effects 0.000 description 1
201000008482 osteoarthritis Diseases 0.000 description 1
229920001277 pectin Polymers 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
230000002085 persistent effect Effects 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
210000001778 pluripotent stem cell Anatomy 0.000 description 1
229920002492 poly(sulfone) Polymers 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
230000008521 reorganization Effects 0.000 description 1
230000008439 repair process Effects 0.000 description 1
239000000565 sealant Substances 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
230000035939 shock Effects 0.000 description 1
210000003491 skin Anatomy 0.000 description 1
239000000758 substrate Substances 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
239000000725 suspension Substances 0.000 description 1
125000003831 tetrazolyl group Chemical group 0.000 description 1
230000003612 virological effect Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3843—Connective tissue
- A61L27/3852—Cartilage, e.g. meniscus

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Dermatology (AREA)
Medicinal Chemistry (AREA)
Oral & Maxillofacial Surgery (AREA)
Transplantation (AREA)
Zoology (AREA)
Chemical Kinetics & Catalysis (AREA)
Botany (AREA)
Cell Biology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Materials For Medical Uses (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

SK822-2003A 2000-12-28 2001-12-27 Use of a biological material containing three-dimensional scaffolds of hyaluronic acid derivatives for the preparation of implants in arthroscopy and kit for instruments for implanting said biological material by arthroscopy SK8222003A3 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
ITMI20002845 IT1320141B1 (it)	2000-12-28	2000-12-28	Uso di materiale biologico comprendente matrici tridimensionali diderivati di acido ialuronico per la preparazione di impianti in
IT2001PD000090A ITPD20010090A1 (it)	2001-04-12	2001-04-12	Strumentario per l'impianto in chirurgia artroscopica di materiale biologico comprendente cellule supportate su matrici tridimensionali bioi
PCT/EP2001/015341 WO2002053201A1 (fr)	2000-12-28	2001-12-27	Utilisation d'une matiere biologique contenant des accrochages tridimensionnels de derives d'acide hyaluronique pour la preparation d'implants en arthroscopie et trousse d'instruments pour l'implant de ladite matiere biologique par arthroscopie

Publications (1)

Publication Number	Publication Date
SK8222003A3 true SK8222003A3 (en)	2003-10-07

Family

ID=26332765

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SK822-2003A SK8222003A3 (en)	2000-12-28	2001-12-27	Use of a biological material containing three-dimensional scaffolds of hyaluronic acid derivatives for the preparation of implants in arthroscopy and kit for instruments for implanting said biological material by arthroscopy

Country Status (14)

Country	Link
US (1)	US7722616B2 (fr)
EP (1)	EP1355684B1 (fr)
JP (1)	JP3839777B2 (fr)
AT (1)	ATE455565T1 (fr)
AU (1)	AU2002219226B2 (fr)
BR (1)	BR0116641A (fr)
CA (1)	CA2433131C (fr)
CZ (1)	CZ20031828A3 (fr)
DE (1)	DE60141166D1 (fr)
ES (1)	ES2340141T3 (fr)
NO (1)	NO20032977L (fr)
PL (1)	PL361732A1 (fr)
SK (1)	SK8222003A3 (fr)
WO (1)	WO2002053201A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR0116641A (pt) *	2000-12-28	2004-02-17	Fidia Advanced Biopolymers S P	Uso de um material biológico contendo armações tridimensionais de derivados de ácido hialurÈnico para preparação de implantes por artroscopia e kit de instrumentos para inserção do dito material biológico por artrocospia
ITPD20040053A1 (it)	2004-02-27	2004-05-27	Fidia Advanced Biopolymers Srl	Biomateriali costituiti da derivati dell'acido ialuronico come nuova terapia di cura per la protezione e la la riparazione della cartilagine articolare danneggiata per osteoartrosi
US8697139B2 (en)	2004-09-21	2014-04-15	Frank M. Phillips	Method of intervertebral disc treatment using articular chondrocyte cells
WO2008067655A1 (fr) *	2006-12-05	2008-06-12	Q6 Biomaterials Inc.	Matrices de reconstruction biocompatibles à base d'hydrogel
CN101134784B (zh) *	2007-08-16	2010-06-16	暨南大学	琼脂糖与透明质酸接枝物及其制备方法与应用
EP3735204B1 (fr)	2018-01-02	2023-09-06	Cartiheal (2009) Ltd.	Outil d'implantation pour substrats solides optimisés favorisant la croissance cellulaire et tissulaire
KR102463375B1 (ko) *	2020-02-07	2022-11-07	한국과학기술연구원	콜라겐을 포함하는 마이크로 젤 조성물 및 제조 방법

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4851521A (en) *	1985-07-08	1989-07-25	Fidia, S.P.A.	Esters of hyaluronic acid
US5736372A (en) *	1986-11-20	1998-04-07	Massachusetts Institute Of Technology	Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
US5623987A (en) *	1992-08-04	1997-04-29	Ergenics, Inc.	Modular manifold gas delivery system
US5906827A (en) *	1994-06-03	1999-05-25	Creative Biomolecules, Inc.	Matrix for the manufacture of autogenous replacement body parts
US5769899A (en) *	1994-08-12	1998-06-23	Matrix Biotechnologies, Inc.	Cartilage repair unit
US5919196A (en) *	1995-02-16	1999-07-06	Arthrex, Inc.	Method and apparatus for osteochondral autograft transplantation
AU5931896A (en) *	1995-06-07	1996-12-30	Advanced Tissue Sciences, Inc.	Apparatus and method for sterilizing, seeding, culturing, st oring, shipping, and testing replacement cartilage tissue co nstructs
US5842477A (en) *	1996-02-21	1998-12-01	Advanced Tissue Sciences, Inc.	Method for repairing cartilage
US5755791A (en) *	1996-04-05	1998-05-26	Purdue Research Foundation	Perforated submucosal tissue graft constructs
US5885829A (en) *	1996-05-28	1999-03-23	The Regents Of The University Of Michigan	Engineering oral tissues
US5921987A (en) *	1996-09-13	1999-07-13	Depuy Orthopaedic Technology, Inc.	Articular cartilage transplant instrument set
US6378527B1 (en) *	1998-04-08	2002-04-30	Chondros, Inc.	Cell-culture and polymer constructs
US6835377B2 (en) *	1998-05-13	2004-12-28	Osiris Therapeutics, Inc.	Osteoarthritis cartilage regeneration
US6224630B1 (en) *	1998-05-29	2001-05-01	Advanced Bio Surfaces, Inc.	Implantable tissue repair device
ITPD980149A1 (it) *	1998-06-17	1999-12-17	Fidia Advanced Biopolymers Srl	Protesi tridimensionali comprendenti derivati dell'acido ialuronico per riparare o ricostruire i tessuti danneggiati e processo per la
KR20010082172A (ko) *	1998-08-14	2001-08-29	추후제출	연골세포 이식을 위한 방법, 기구 및 물질
US6530956B1 (en) *	1998-09-10	2003-03-11	Kevin A. Mansmann	Resorbable scaffolds to promote cartilage regeneration
AU768641B2 (en) *	1998-10-12	2003-12-18	Massachusetts Institute Of Technology	Composites for tissue regeneration and methods of manufacture thereof
IT1302534B1 (it) *	1998-12-21	2000-09-05	Fidia Advanced Biopolymers Srl	Composizioni iniettabili, biocompatibili e biodegradabili comprendentialmeno un derivato dell'acido ialuronico, cellule condrogeniche, per
US6333029B1 (en) *	1999-06-30	2001-12-25	Ethicon, Inc.	Porous tissue scaffoldings for the repair of regeneration of tissue
US6652872B2 (en) *	1999-07-06	2003-11-25	Ramat At Tel Aviv University Ltd.	Scaffold formed of tissue treated to eliminate cellular and cytosolic elements
US7033603B2 (en) *	1999-08-06	2006-04-25	Board Of Regents The University Of Texas	Drug releasing biodegradable fiber for delivery of therapeutics
AU6526100A (en) *	1999-08-06	2001-03-05	Board Of Regents, The University Of Texas System	Drug releasing biodegradable fiber implant
BR0116641A (pt) *	2000-12-28	2004-02-17	Fidia Advanced Biopolymers S P	Uso de um material biológico contendo armações tridimensionais de derivados de ácido hialurÈnico para preparação de implantes por artroscopia e kit de instrumentos para inserção do dito material biológico por artrocospia

2001
- 2001-12-27 BR BR0116641-7A patent/BR0116641A/pt not_active IP Right Cessation
- 2001-12-27 CA CA2433131A patent/CA2433131C/fr not_active Expired - Lifetime
- 2001-12-27 DE DE60141166T patent/DE60141166D1/de not_active Expired - Lifetime
- 2001-12-27 ES ES01272673T patent/ES2340141T3/es not_active Expired - Lifetime
- 2001-12-27 AT AT01272673T patent/ATE455565T1/de active
- 2001-12-27 WO PCT/EP2001/015341 patent/WO2002053201A1/fr not_active Ceased
- 2001-12-27 AU AU2002219226A patent/AU2002219226B2/en not_active Ceased
- 2001-12-27 EP EP01272673A patent/EP1355684B1/fr not_active Expired - Lifetime
- 2001-12-27 CZ CZ20031828A patent/CZ20031828A3/cs unknown
- 2001-12-27 PL PL36173201A patent/PL361732A1/xx unknown
- 2001-12-27 SK SK822-2003A patent/SK8222003A3/sk unknown
- 2001-12-27 JP JP2002554150A patent/JP3839777B2/ja not_active Expired - Fee Related
- 2001-12-27 US US10/250,408 patent/US7722616B2/en not_active Expired - Fee Related
2003
- 2003-06-27 NO NO20032977A patent/NO20032977L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU2002219226B2 (en)	2007-03-22
CZ20031828A3 (cs)	2003-11-12
BR0116641A (pt)	2004-02-17
PL361732A1 (en)	2004-10-04
EP1355684B1 (fr)	2010-01-20
US7722616B2 (en)	2010-05-25
ES2340141T3 (es)	2010-05-31
WO2002053201A1 (fr)	2002-07-11
JP3839777B2 (ja)	2006-11-01
CA2433131A1 (fr)	2002-07-11
CA2433131C (fr)	2012-10-23
ATE455565T1 (de)	2010-02-15
EP1355684A1 (fr)	2003-10-29
DE60141166D1 (de)	2010-03-11
NO20032977L (no)	2003-08-21
JP2004516892A (ja)	2004-06-10
NO20032977D0 (no)	2003-06-27
US20040044416A1 (en)	2004-03-04

Legal Events

Date	Code	Title	Description
2011-02-04	FB9A	Suspension of patent application procedure

Publication	Publication Date	Title
Keilhoff et al.	2003	Bio-compatibility of type I/III collagen matrix for peripheral nerve reconstruction
US6340369B1 (en)	2002-01-22	Treating degenerative disc disease with harvested disc cells and analogues of the extracellular matrix
ES2250642T3 (es)	2006-04-16	Injertos para la preparacion de efectos osteocondrales.
DE69626560T2 (de)	2003-12-24	Laminare Knochengrundlage für das Knorpelwachstum
CN101020082B (zh)	2010-06-30	一种骨修复材料及其制备方法和用途
Singh et al.	2022	Generation of hybrid tissue engineered construct through embedding autologous chondrocyte loaded platelet rich plasma/alginate based hydrogel in porous scaffold for cartilage regeneration
US20020183857A1 (en)	2002-12-05	Vascular tissue composition
ITPD980298A1 (it)	2000-06-21	Composizioni iniettabili, biocompatibili e biodegradabili comprendenti almeno un derivato dell'acido ialuronico, cellule condrogeniche, per il trattamento dei difetti della cartilagine.
JP4856309B2 (ja)	2012-01-18	ヒアルロン酸誘導体を含んでいる三次元人工器官及びそれらの調製工程
CZ297205B6 (cs)	2006-10-11	Zpusob výroby vícevrstevné membrány, vícevrstevnámembrána a její pouzití
US20100297239A1 (en)	2010-11-25	Osseointegrative meniscus and cartilage implants based on beta-glucan nanocomposites
US6872819B1 (en)	2005-03-29	Biomaterials containing hyaluronic acid derivatives in the form of three-dimensional structures free from cellular components or products thereof for the in vivo regeneration of tissue cells
US7722616B2 (en)	2010-05-25	Use of a biological material containing three-dimensional scaffolds of hyaluronic acid derivatives for the preparation of implants in arthroscopy and kit for instruments for implanting said biological material by arthroscopy
AU2002219226A1 (en)	2003-01-23	Use of a biological material containing three-dimensional scaffolds of hyaluronic acid derivatives for the preparation of implants in arthroscopy and kit for instruments for implanting said biological materials by arthroscopy
DE102009024133A1 (de)	2010-12-09	Bakterielle Nanocellulose zur Knorpelneubildung
RU2240135C1 (ru)	2004-11-20	Культура клеток, содержащая клетки-предшественники остеогенеза, имплантат на ее основе и его использование для восстановления целостности кости
EP1385559B1 (fr)	2005-01-12	Matrices poreuses et non poreuses a base de chitosane et d'acides hydroxycarboxyliques
De Olivera et al.	2004	Peripheral nerve regeneration through the nerve tubulization technique
Essawy et al.	2019	Biocompatible chitosan in unique applications for tissue engineering
EP3517116A1 (fr)	2019-07-31	Structure réticulaire pour la régénération et l'ingénierie tissulaire et son procédé de synthèse
JP2003126238A (ja)	2003-05-07	骨および骨軟骨再生基材
Wasserman et al.	1988	Clinical applications of electron microscopy in the analysis of collagenous biomaterials
ITMI20002845A1 (it)	2002-06-28	Uso di materiale biologico comprendente matrici tridimensionali di derivati di acido ialuronico per la preparazione di impianti in artroscop
Li et al.	2013	Progress in cartilage tissue engineering with nanostructured extracellular matrix
Tognana	2008	Scaffolds based on hyaluronan derivatives in biomedical applications